Table 4 Effects of IFT20 and GM130 protein expressions on the survival of patients with lung adenocarcinoma by stratified analysis
Proteins | Variables | Differentiated types | Tumor size | TNM stage | Lymphatic metastasis | Distant metastasis | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Poorly | moderately to well | > 7 cm | ≤7 cm | II ~ IV | I | Yes | No | Yes | No | ||
IFT20 | IOD/area | 1.17(0.93,1.48) | 0.89(0.74,1.07) | 0.84(0.47,1.52) | 1.00(0.85,1.18) | 0.98(0.83,1.15) | 1.02(0.67,1.56) | 1.03(0.85,1.25) | 0.92(0.74,1.14) | 1.07(0.78,1.46) | 0.97(0.82,1.16) |
| Â | Rate of positive cells | 1.01(0.99,1.02) | 1.00(0.99,1.01) | 1.03(0.99,1.07) | 1.00(0.99,1.01) | 1.00(0.99,1.01) | 0.99(0.96,1.02) | 1.00(0.99,1.01) | 1.00(0.98,1.01) | 1.02(1.00,1.04) | 1.00(0.99,1.01) |
| Â | Staining intensity score | 1.12(0.87,1.45) | 0.85(0.70,1.04) | 0.91(0.53,1.56) | 0.94(0.80,1.10) | 0.87(0.74,1.03) | 1.07(0.66,1.73) | 0.93(0.76,1.12) | 0.92(0.67,1.27) | 1.37(0.97,1.94) | 0.84(0.71,0.99) |
GM130 | IOD/area | 0.86(0.59,1.27) | 0.95(0.80,1.12) | 0.46(0.26,0.82) | 0.98(0.82,1.18) | 0.91(0.76,1.08) | 1.07(0.69,1.67) | 1.01(0.80,1.27) | 0.91(0.74,1.12) | 0.35(0.20,0.62) | 0.99(0.98,1.19) |
| Â | Rate of positive cells | 1.00(0.98,1.02) | 0.99(0.97,1.01) | 0.96(0.92,0.99) | 0.99(0.98,1.01) | 0.99(0.98,1.01) | 1.02(0.99,1.06) | 1.00(0.99,1.02) | 0.98(0.96,1.01) | 0.97(0.95,0.99) | 0.99(0.98,1.01) |
| Â | Staining intensity score | 0.98(0.77,1.25) | 0.89(0.75,1.06) | 0.85(0.50,1.44) | 0.93(0.80,1.07) | 0.88(0.76,1.02) | 1.33(0.87,2.01) | 0.93(0.78,1.11) | 0.88(0.69,1.14) | 0.75(0.58,0.97) | 0.92(0.78,1.08) |